Skip to main navigation
About
About Vistagen
Leadership
Board of Directors
Advisory Board
Pipeline
Pipeline Overview
Pipeline Overview
Partnering
Fasedienol (PH94B)
Fasedienol Overview
Social Anxiety Disorder
Itruvone (PH10)
Itruvone Overview
Major Depressive Disorder
AV-101
AV-101 Overview
PH15
PH15 Overview
Refisolone (PH80)
Refisolone Overview
PH284
PH284 Overview
Expanded Access Policy
Publications
Fasedienol (PH94B)
Itruvone (PH10)
Refisolone (PH80)
AV-101
News & Media
Press Releases
Videos
Media Resources
Presentations
Investors
Investors Overview
Company Profile
Key Contact Info
FAQs
Presentations
Email Alerts
Stock Information
Stock Quote & Chart
Historical Data
Analyst Coverage
Press Releases
Events
SEC Filings
All SEC Filings
Annual Reports
Quarterly Results
Section 16 Filings
Corporate Governance
Executive Team
Board Committees
Documents & Charters
Careers
Careers
Culture
Our Purpose
Corporate Responsibility
Diversity & Inclusion
Finding Support
Contact
Investing in innovation to fortify the future of mental health care
Event
Vistagen Reports Corporate Update
Jun 30, 2026
at 8:30 AM EDT
Webcast
Key Contact Info
FAQ
Presentations
Email Alerts
Key Contact Info
FAQ
Presentations
Email Alerts